Pharma Equity Group A/S
CSE:PEG
Pharma Equity Group A/S
Other Items
Pharma Equity Group A/S
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Pharma Equity Group A/S
CSE:PEG
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Other Items
-kr1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Other Items
-kr5.8m
|
CAGR 3-Years
61%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Other Items
-kr285.5m
|
CAGR 3-Years
-141%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-2%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Other Items
-kr20.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Other Items
kr71.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.